Cargando…

CD300LG improves the cytotoxic activity of CIK

To investigate the effect of CD300LG-γ induction on the cytotoxic activity of CIK. Eukaryotic expression plasmid hCD300LG-γ/pEGFP-C3, which can express human CD300LG-γ, was constructed and transfected into CHO cells by lipofectamine. The expression of CD300LG-γ was confirmed by immunofluorescence, R...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiuyue, Liu, Yuqing, Chen, Ying, Wang, Ke, Xie, Wensheng, Wei, Dapeng, Hu, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573884/
https://www.ncbi.nlm.nih.gov/pubmed/28860929
http://dx.doi.org/10.5114/ceji.2017.69352
_version_ 1783259730347556864
author Wang, Qiuyue
Liu, Yuqing
Chen, Ying
Wang, Ke
Xie, Wensheng
Wei, Dapeng
Hu, Lijuan
author_facet Wang, Qiuyue
Liu, Yuqing
Chen, Ying
Wang, Ke
Xie, Wensheng
Wei, Dapeng
Hu, Lijuan
author_sort Wang, Qiuyue
collection PubMed
description To investigate the effect of CD300LG-γ induction on the cytotoxic activity of CIK. Eukaryotic expression plasmid hCD300LG-γ/pEGFP-C3, which can express human CD300LG-γ, was constructed and transfected into CHO cells by lipofectamine. The expression of CD300LG-γ was confirmed by immunofluorescence, RT-PCR, and Western Blot. To produce CIK cells, human peripheral blood mononuclear cells (PBMC) were isolated and induced, respectively, by cell lysates extracted from hCD300LG-γ/CHO cells, pEGFP-C3/CHO cells, and CHO cells, concurrently with the standard CIK inductive agent. The cytotoxic activity of these CIK cells against hCD300LG-γ/CHO cells, pEGFP-C3/CHO cells, CHO cells, and K562 cells was tested. The results showed that eukaryotic expression of plasmid hCD300LG-γ/pEGFP-C3 was constructed and transfected into CHO cells successfully. After being induced by cell lysates, the cytotoxicity of hCD300LG-γ/CHO-CIK was improved compared with the other CIK cells. In particular, the activity of killing pEGFP-C3/CHO and CHO cells was improved significantly. Meanwhile, the activity of hCD300LG-γ/CHO-CIK killing K562 was improved significantly compared with the other CIK cells. The results indicated that hCD300LG-γ induction can significantly improve the killing activity of CIK cells.
format Online
Article
Text
id pubmed-5573884
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Polish Society of Experimental and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-55738842017-08-31 CD300LG improves the cytotoxic activity of CIK Wang, Qiuyue Liu, Yuqing Chen, Ying Wang, Ke Xie, Wensheng Wei, Dapeng Hu, Lijuan Cent Eur J Immunol Experimental Immunology To investigate the effect of CD300LG-γ induction on the cytotoxic activity of CIK. Eukaryotic expression plasmid hCD300LG-γ/pEGFP-C3, which can express human CD300LG-γ, was constructed and transfected into CHO cells by lipofectamine. The expression of CD300LG-γ was confirmed by immunofluorescence, RT-PCR, and Western Blot. To produce CIK cells, human peripheral blood mononuclear cells (PBMC) were isolated and induced, respectively, by cell lysates extracted from hCD300LG-γ/CHO cells, pEGFP-C3/CHO cells, and CHO cells, concurrently with the standard CIK inductive agent. The cytotoxic activity of these CIK cells against hCD300LG-γ/CHO cells, pEGFP-C3/CHO cells, CHO cells, and K562 cells was tested. The results showed that eukaryotic expression of plasmid hCD300LG-γ/pEGFP-C3 was constructed and transfected into CHO cells successfully. After being induced by cell lysates, the cytotoxicity of hCD300LG-γ/CHO-CIK was improved compared with the other CIK cells. In particular, the activity of killing pEGFP-C3/CHO and CHO cells was improved significantly. Meanwhile, the activity of hCD300LG-γ/CHO-CIK killing K562 was improved significantly compared with the other CIK cells. The results indicated that hCD300LG-γ induction can significantly improve the killing activity of CIK cells. Polish Society of Experimental and Clinical Immunology 2017-08-08 2017 /pmc/articles/PMC5573884/ /pubmed/28860929 http://dx.doi.org/10.5114/ceji.2017.69352 Text en Copyright: © 2017 Polish Society of Experimental and Clinical Immunology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Experimental Immunology
Wang, Qiuyue
Liu, Yuqing
Chen, Ying
Wang, Ke
Xie, Wensheng
Wei, Dapeng
Hu, Lijuan
CD300LG improves the cytotoxic activity of CIK
title CD300LG improves the cytotoxic activity of CIK
title_full CD300LG improves the cytotoxic activity of CIK
title_fullStr CD300LG improves the cytotoxic activity of CIK
title_full_unstemmed CD300LG improves the cytotoxic activity of CIK
title_short CD300LG improves the cytotoxic activity of CIK
title_sort cd300lg improves the cytotoxic activity of cik
topic Experimental Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573884/
https://www.ncbi.nlm.nih.gov/pubmed/28860929
http://dx.doi.org/10.5114/ceji.2017.69352
work_keys_str_mv AT wangqiuyue cd300lgimprovesthecytotoxicactivityofcik
AT liuyuqing cd300lgimprovesthecytotoxicactivityofcik
AT chenying cd300lgimprovesthecytotoxicactivityofcik
AT wangke cd300lgimprovesthecytotoxicactivityofcik
AT xiewensheng cd300lgimprovesthecytotoxicactivityofcik
AT weidapeng cd300lgimprovesthecytotoxicactivityofcik
AT hulijuan cd300lgimprovesthecytotoxicactivityofcik